EndoGastric Solutions Stock
EndoGastric Solutions is a medical device company focused on innovative, incisionless treatments for gastroesophageal reflux disease (GERD). Its primary product is the EsophyX device used in the TIF 2.0 procedure – a minimally invasive, endoscopic technique that reconstructs the valve between the stomach and esophagus.
Founded: 2002
For more EndoGastric Solutions stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Darin Hammers President and CEO |
| Brett Reynolds CFO |
